MORNEAU MICHAEL
Insider CIK 1517780 · TSRX VPF and CAO · VKTX VP, Finance and Administration
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-19 | 2021-01-19 | 1,685 | $6.68 | $11.3K | 116,062 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 33,000 | — | $0 | 33,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 14,667 | — | $0 | 113,819 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 6,667 | — | $0 | 120,486 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-04 | 2021-01-06 | 2,739 | $5.80 | $15.9K | 117,747 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2020-09-15 | 2020-09-16 | 4,500 | — | $0 | 99,430 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2020-09-15 | 2020-09-16 | 1,557 | $6.25 | $9.7K | 97,873 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-03-31 | 2020-04-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2020-01-19 | 2020-01-21 | 2,044 | $7.18 | $14.7K | 92,840 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-10-31 | 2019-10-31 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-07-31 | 2019-08-02 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2019-01-19 | 2019-01-22 | 2,044 | $8.78 | $17.9K | 91,991 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-01-03 | 2019-01-03 | 29,000 | — | $0 | 29,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2018-05-31 | 2018-05-31 | 21,551 | $9.25 | $199.3K | 94,035 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2018-05-04 | 2018-05-08 | 7,616 | $4.22 | $32.1K | 94,035 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2018-01-19 | 2018-01-23 | 52,500 | — | $0 | 52,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2018-01-19 | 2018-01-23 | 15,000 | — | $0 | 101,651 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2017-05-04 | 2017-05-05 | 8,192 | $1.34 | $11.0K | 80,604 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-01-05 | 2017-01-05 | 95,000 | — | $0 | 95,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-01-05 | 2017-01-05 | 17,605 | — | $0 | 17,605 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-03-14 | 2016-03-15 | 19,934 | — | $0 | 19,934 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-03-04 | 2016-03-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 25,500 | — | $0 | 25,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2015-05-04 | 2015-05-06 | 10,404 | $9.49 | $98.7K | 77,404 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2015-05-04 | 2015-05-06 | 67,000 | — | $0 | 67,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 80,000 | $9.50 | $760.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 15,000 | $8.35 | $125.3K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 30,000 | $7.37 | $221.1K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer | 2013-09-11 | 2013-09-13 | 14,070 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise deriv | 2013-07-11 | 2013-07-12 | 20,000 | — | $0 | 80,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-07-11 | 2013-07-12 | 20,000 | $9.75 | $195.0K | 12,545 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise | 2013-07-11 | 2013-07-12 | 20,000 | $4.00 | $80.0K | 32,545 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise deriv | 2013-05-14 | 2013-05-16 | 20,000 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-05-14 | 2013-05-16 | 20,000 | $7.75 | $155.0K | 10,635 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise | 2013-05-14 | 2013-05-16 | 20,000 | $4.00 | $80.0K | 30,635 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-03-07 | 2013-03-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-02-22 | 2012-03-12 | 15,000 | — | $0 | 15,000 | SEC↗ |